Average Co-Inventor Count = 7.51
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (37 from 1,970 patents)
2. Syntex (u.s.a.) Inc. (13 from 932 patents)
3. Roche Palo Alto LLC (5 from 322 patents)
4. Agouron Pharmaceuticals, Inc. (5 from 174 patents)
5. Other (3 from 832,680 patents)
6. Array Biopharma Inc. (2 from 329 patents)
7. Hoffmann-la Roche Inc. (1 from 4,942 patents)
8. The Scripps Research Institute (1 from 1,186 patents)
9. Poche Palo Alto LLC (1 from 1 patent)
61 patents:
1. 12459932 - KIF18A inhibitors
2. 12441705 - KIF18A inhibitors
3. 12441736 - KIF18A inhibitors
4. 12440491 - KRAS G12C inhibitors and methods of using the same
5. 12083121 - Substituted piperazines as KRAS G12C inhibitors
6. 12054476 - KIF18A inhibitors
7. 11905281 - KRAS G12C inhibitors and methods of using the same
8. 11766436 - KRAS G12C inhibitors and methods of using the same
9. 11708348 - Protease inhibitors for treatment of coronavirus infections
10. 11285156 - Substituted piperazines as KRAS G12C inhibitors
11. 11236069 - KIF18A inhibitors
12. 11090304 - KRAS G12C inhibitors and methods of using the same
13. 10889581 - Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
14. 10519146 - KRAS G12C inhibitors and methods of using the same
15. 9718803 - Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors